Medical Journals

Ccr4-expressing T Cell Tumors Can Be Specifically Controlled Via Delivery of Toxins to Chemokine Receptors.

Authors:
  • Baatar Dolgor
  • Olkhanud Purevdorj
  • Newton Dianne
  • Sumitomo Kenya
  • Biragyn Arya

From: Laboratory of Immunology, Gerontology Research Center, National Institute on Aging, Baltimore, MD 21224, USA.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Aug 2007
  • ISSN: 0022-1767
  • Volume: 179
  • Issue: 3
  • Pages: 1996-2004
  • Medium: Print
  • Language: English
  • Citation (JAMA): Baatar Dolgor, Olkhanud Purevdorj, Newton Dianne, et al. Ccr4-expressing T Cell Tumors Can Be Specifically Controlled Via Delivery of Toxins to Chemokine Receptors.. J. Immunol. Aug 2007;179:1996-2004

Abstract

Expression of chemokine receptors by tumors, specifically CCR4 on cutaneous T cell lymphomas, is often associated with a poor disease outcome. To test the hypothesis that chemokine receptor-expressing tumors can be successfully controlled by delivering toxins through their chemokine receptors, we have generated fusion proteins designated chemotoxins: chemokines fused with toxic moieties that are nontoxic unless delivered into the cell cytosol. We demonstrate that chemokines fused with human RNase eosinophil-derived neurotoxin or with a truncated fragment of Pseudomonas exotoxin 38 are able to specifically kill tumors in vitro upon internalization through their respective chemokine receptors. Moreover, treatment with the thymus and activation-regulated chemokine (CCL17)-expressing chemotoxin efficiently eradicated CCR4-expressing cutaneous T cell lymphoma/leukemia established in NOD-SCID mice. Taken together, this work represents a novel concept that may allow control of growth and dissemination of tumors that use chemokine receptors to metastasize and circumvent immunosurveillance.

Mesh Headings (Keywords): ADP Ribose Transferases, Animals, Antineoplastic Agents, Bacterial Toxins, Cell Death, Cell Line, Cell Line, Tumor, Chemokine CCL17, Chemokines, CC, Cytotoxicity, Immunologic, Eosinophil-Derived Neurotoxin, Exotoxins, Female, Humans, Immunotoxins, Leukemia-Lymphoma, Adult T-Cell, Mice, Mice, Inbred NOD, Mice, SCID, Neoplasm Recurrence, Local, Receptors, CCR4, Receptors, Chemokine, Viral Proteins, Virulence Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17641067


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.